MedTech Dive February 24, 2025
Susan Kelly

The brain-computer interface technology personalizes therapy based on an individual’s brain activity.

Dive Brief:

  • Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for people with Parkinson’s disease, a movement disorder of the nervous system.
  • The adaptive BrainSense device self-adjusts therapy to a person’s brain activity, minimizing the need for manual adjustments. The approval was the first of an adaptive DBS device for Parkinson’s, Medtronic said in a Monday announcement.
  • Medtronic claims the launch of the system will be the largest ever commercial rollout of a brain-computer interface technology.

Dive Insight:

Medtronic’s DBS system uses an implanted neurostimulator to transmit electrical signals to areas of the brain affected by neurological disorders,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: FDA, Govt Agencies, Medical Devices, Patient / Consumer, Provider
Related Articles:
FDA approves first adaptive deep brain stimulation system for Parkinson’s
Chinese medical devices are in health systems across U.S., and the government and hospitals are worried
Siemens raises $1.5B by selling stake in Healthineers imaging division
Valencia Technologies Secures Strategic Investment of $35 Million from Brooks Advisory Group, Appoints James D. Surek as CEO
Device industry scrambles as FDA job cuts cause delays

Share This Article